
Kimera® Labs Receives FDA Phase I/IIa IND Clearance For Its MSC Exosomes Human Study
MIRAMAR, Fla., May 16, 2023 /PRNewswire/ — Kimera® Labs Inc., the first and leading worldwide MSC exosome research lab and producer, is pleased to announce the FDA IND (Investigational New Drug)